Can we produce an image of bacteria with radiopharmaceuticals?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 6, 2008, Pages 1051-1055

  Signore, A ^a,b,d   D'Alessandria, C ^a   Lazzeri, E ^c   Dierckx, R ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF PISA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN TC 99M; ISONIAZID TC 99M; RADIOPHARMACEUTICAL AGENT; SPARFLOXACIN TC 99M; TECHNETIUM 99M; UBI 29-41 TC 99M;

BACTERIAL INFECTION; BACTERIUM; EDITORIAL; GRANULOCYTE; IMAGING; ISOTOPE LABELING; MONOCYTE; NONHUMAN;

BACTERIA; BACTERIAL INFECTIONS; HUMANS; NUCLEAR MEDICINE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 43749088470     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0762-9     Document Type: Editorial

References (37)

1. Akhtar MS, Khan ME, Khan B, Irfanullah J, Afzal MS, Khan MA, et al. An imaging analysis of 99mTc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging 2008. DOI 10.1007/s00259-007-0671-3.
2. Welling M, Stokkel M, Balter J, Sarda-Mantel L, Meulemans A, Le Guludec D. The many roads to infection imaging. Eur J Nucl Med Mol Imaging 2008;35. DOI 10.1007/s00259-007-0695-8.
3. Lucignani G. The many roads to infection imaging. Eur J Nucl Med Mol Imaging. 2007;34(11):1873-7.
4. 99mTc-ciprofloxacin (Infecton). J Clin Pathol. 2002;55:817-823.
5. 99mTc-Infecton, a novel agent for detecting site of infection. J Clin Pathol. 1996;51:215-219.
6. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Crémieux AC, Le Guludec D. Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med. 2002;43(2):239-45.
7. Sarda L, Crémieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44(6):920-6.
8. Siaens RH, Rennen HJ, Boerman OC, Dierckx R, Slegers G. Synthesis and comparison of Tc-99m-enrofloxacin and Tc-99m-ciprofloxacin. J Nucl Med. 2004;45(12):2088-94.
9. Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, et al. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging. 2005;32(2):143-50.
10. Singh AK, Verma J, Bhatnagar A, Ali A. Tc-99m labeled sparfloxacin: a specific infection imaging agent. W J Nucl Med. 2003;2(2):103-109.
11. Martin-Comin J, Soroa V, Rabiller G, Galli R, Cuesta L, Roca M. Diagnosis of bone infection with 99mTc-ceftizoxime. Rev Esp Med Nucl. 2004;23(5):357.
12. Gomes Barreto V, Rabiller G, Iglesias F, Soroa V, Tubau F, Roca M, et al. 99mTc-ceftizoxime scintigraphy in normal rats and abscess induced rats. Rev Esp Med Nucl. 2005;24(5):312-8.
13. Fischman AJ, Livni E, Babich J, Alpert NM, Liu YY, Thom E, et al. Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Chemother. 1992;36(10):2286-92.
14. Singh AK, Verma J, Bhatnagar A, Sen S, Bose M. Tc-99 isoniazid: a specific agent for diagnosis of tuberculosis. W J Nucl Med. 2003;2:292-305.
15. Causse JE, Pasqualini R, Cypriani B, Weil R, Van der Valk R, Bally P, et al. Labelling of ethambutol with 99mTc; using a new reduction procedure. Pharmacokinetic study in the mouse and rat. Int J Rad Appl Instrum (A). 1990;41(5):493-6.
16. Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3(4):223-9.
17. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42(5):788-94.
18. Lupetti A, Pauwels EKJ, Nibbering PH, Welling MM. 99mTc-antimicrobial peptides: promising candidates for infection imaging. Q J Nucl Med. 2003;47:258-45.
19. Nibbering PH, Welling M, van den Broek PJ, Pauwels EKJ. Radiolabelled antimicrobial peptides for imaging of infection: a review. Nucl Med Comm. 1998;19:1117-21. Dec.
20. 99mTc-UBI in humans. Nucl Med Biol. 2004;31:373-9.
21. Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B, et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849-856.
22. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292-301.
23. Zijlstra S, Gunawan J, Freytag C, Burchert W. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet. Appl Radiat Isot. 2006;64(7):802-7.
24. Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Calame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med. 1999;40:2073-80.
25. Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ. Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med. 2004;45(7):1201-8.
26. 111In-biotin. Spine 2008 (in press).
27. Zasloff M. Antimicrobial peptides of multicellular organism. Nature. 2002;415:389-95.
28. Cudic M, Otvos L. Intracellular targets of antimicrobial peptides. Current Drug Targets. 2002;3:101-6.
29. Hancock REW, Rozek A. Role of membrane in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett. 2002;206:143-9.
30. Alexander K, Drost WT, Mattoon JS, Kowalski JJ, Funk JA, Crabtree AC. Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coli. Can J Vet Res. 2005;69(4):272-7.
31. Sistrom WR. Microbial life. New York: Holt, Rinehart and Winston; 1969.
32. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385-94.
33. Zimmerli W, Trampuz A, Ochsner P. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
34. Bounds SJ, Nakkula R, Walters JD. Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage. Antimicrob Agents Chemother. 2000;44(10):2609-14. Oct.
35. Walters JD, Zhang F, Nakkula RJ. Mechanisms of fluoroquinolone transport by human neutrophils. Antimicrob Agents Chemother. 1999;43(11):2710-5. Nov.
36. Walters JD, Nakkula RJ. Ciprofloxacin transport by chemoattractant- activated polymorphonuclear leukocytes: regulation by priming and protein kinase C. Antimicrob Agents Chemother. 2003;47(10):3345-8. Oct.
37. Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982;21(3):373-80. Mar.